Vaxxinity Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 8.82M and sold 1.54M VAXX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 8.82M shares
Sell 1.54M shares
62% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 07, 2023
Buy
Stock Option (right to buy)
A-Award
Pesile Jason
See Remarks
Officer 32 700
Value: $74.9K
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Common Stock
J-Other
Toledano Gabrielle B
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Common Stock
J-Other
Toledano Gabrielle B
Director 0
Value: $0
Feb 01, 2023
Buy
Common Stock
J-Other
Eade Katherine A.
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Ogilvie Landon E
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Common Stock
J-Other
Eade Katherine A.
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Smith James Alan
Director
Director 0
Value: $0
Feb 01, 2023
Buy
Class A common stock
Ogilvie Landon E
Director
Director 0
Value: $0
Jan 23, 2023
Sell
Class A common stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 405 217
Value: $1.36M
Jan 23, 2023
Sell
Class A common stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 95 475
Value: $320.0K
Jan 23, 2023
Sell
Class A common stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 405 217
Value: $1.36M
Jan 23, 2023
Sell
Class A common stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 95 475
Value: $320.0K
Dec 02, 2022
Sell
Class A Common Stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 11 121
Value: $28.6K
Dec 02, 2022
Sell
Class A Common Stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 2 620
Value: $7K
Dec 01, 2022
Sell
Class A Common Stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 270 964
Value: $805.2K
Dec 01, 2022
Sell
Class A Common Stock
S-Sale
Prime Movers Lab Fund I Lp
Director
Director 63 843
Value: $189.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VAXXINITY, INC.
Vaxxinity
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synu...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE